Results 141 to 150 of about 4,659,967 (205)

Plasmodium yoelii infection induces lung injury by modulating type 2 conventional dendritic cells autophagy via the STAT3-IRF4 signaling. [PDF]

Cell Death Dis
Hong C, Deng G, Jiang Z, Lu Y, Wu Q, Huang C, Tang J, Zhou H, Liu Q, Luo X, Zhao Y, Qi Y, Li Q, Ma X, Yang Q.   +14 more
europepmc   +1 more source

cdc2 protein kinase: interactions with cyclins and suc1.

Cold Spring Harbor symposia on quantitative biology, 1992
P, Brambilla, B, Ducommun, G, Draetta
openaire   +1 more source

Control of Intestinal Type 3 Immunity by the Unfolded Protein Response Sensor Inositol-Requiring Enzyme 1α in Antigen-Presenting Cells. [PDF]

Cell Mol Gastroenterol Hepatol
Fernández D, Geisse A, González-Maldonado P, Tapia A, Gutiérrez-Ballesteros F, Ugalde V, Tapia F, Flores-Santibañez F, Iwawaki T, Pino-Lagos K, Boon L, Bono MR, Prado C, Pacheco R, Osorio F.   +14 more
europepmc   +1 more source

Phosphorylation landscape of dengue virus proteins and their implications in protein-protein interactions. [PDF]

PLoS One
Agrawal P, Yadav R, Madhumalar A, Senthil Kumar G.   +3 more
europepmc   +1 more source

Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells. [PDF]

Nat Commun
Caro AA, Kancheva D, Hadadi E, Boeckx B, De Nolf C, Bardet PMR, Verstaen K, Li L, Oueslati L, Figueras-Duch N, Elkrim Y, Vandamme N, Deschoemaeker S, Blomme A, Close P, Janssens S, De Palma M, Lambrechts D, Coosemans A, Laoui D.   +19 more
europepmc   +1 more source

Optimizing pyrazine-2-carboxamide derivatives as dual FLT3/HDAC inhibitors with enhanced pharmacokinetics and immunotherapeutic potential. [PDF]

Acta Pharm Sin B
Chang Y, Li X, Wang H, Zhao H, Zhou Y, Bi W, Cheng R, Shi Y, Weng H, Yang X, Zhao W, Fang H, Hou X.   +12 more
europepmc   +1 more source

Systems-Driven Identification and Experimental Validation of Actinomycetes-Derived Secondary Metabolites as Promising Antileishmanial Agents Targeting <i>Leishmania donovani</i> Methionyl-tRNA Synthetase. [PDF]

ACS Med Chem Lett
Singh S, Baghel K, Bhalerao P, Bhatt TK, Prusty D, Prajapati VK.   +5 more
europepmc   +1 more source

Synergistic Anticancer Effects of Lenvatinib Combined with N-butylidenephthalide in Human Colorectal Cancer Cells. [PDF]

Int J Med Sci
Yu CC, Huang SY, Chang SF, Kuo YH, Liao KF, Chiu SC.   +5 more
europepmc   +1 more source

A Specific Inhibitor of Cyclin-dependent Protein Kinases, CDC2 and CDK2

Molecules and Cells, 1996
Sang Gon Park, Je Young Cheon, Yong Hee Lee, Joo-Seop Park, Kwang Youl Lee, Chul Hoon Lee, Seung Ki Lee   +6 more
openaire   +1 more source

KRAS is required for plexiform neurofibroma formation and represents a targetable vulnerability in established tumors. [PDF]

Sci Adv
Hu L, Ahmari N, Schaeper A, Pundavela J, Kim MO, Dombi E, Wu J, Brunmair J, Petronczki ÖY, Ratner N.   +9 more
europepmc   +1 more source